Patent expirations are contributing to M&A fever in the biotech sector.
The pharmaceutical company's new CEO formerly worked for the Canadian company, long a rumored suitor.
Keep an eye on these retailers as they report earnings this week.
Earnings issues linger in every sector and guidance disappoints.
The biotech was rumored to be a takeover target but aims to be a buyer instead.
A couple companies reporting this week are looking for a spark to turn around dismal stock performances, while others are hoping to keep upward momentum alive.
When you take out the volatile energy sector, the EPS growth rate is only 3.22%.
VIDEO ON MSN MONEY
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
The IRS is struggling to combat identify thieves who file fraudulent tax returns in the names of older residents who don't need to file.